Navigation Links
Access To Debut Electronic Signature 8.0 at HIMSS17 Booth 1778
Date:2/17/2017

Access today announced that it will introduce Electronic Signature 8.0 at the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will be the first to preview the latest version of the most widely used electronic patient signatures solution in healthcare.

Since it first introduced Electronic Signature more than 10 years ago, Access has continually gathered feedback from hospitals worldwide, which it has combined with a forward-thinking approach to create user-friendly updates that improve the patient experience and save time, money and paper for hospitals. Following robust testing in real-world scenarios, the company is confident that Electronic Signature 8.0 is the most advanced yet intuitive iteration to date. New features enable users to:

  •     Hand off eForms digitally from one device to another, like an iPad or Microsoft Surface tablet, to make signature capture as mobile as necessary (useful when another department takes over a patient’s care, such as when they move into surgery).
  •     Collect electronic patient signatures on consents and all other documents in registration, at the bedside or any other location using virtually any device.
  •     Empower the collection of additional information during the signing process and the automation of workflow by routing the signed eForm to other staff for signature or review automatically.
  •     Enhance interoperability by integrating signed eForms with healthcare information (HIS), content management (ECM), enterprise resource planning (ERP) and other clinical and business systems.
  •     Manage all eForms that require signatures in one, web-based location—Access Passport—regardless of whether they are needed to drive clinical processes or administrative workflows.
  •     Move seamlessly from traditional, on-demand printed forms to 100 percent paperless, electronically signed eForms.

“We share our customers’ commitment to delivering the best possible patient care and service,” said Access founder and CEO Tim Elliott. “The hand-off functionality and other features of Electronic Signature 8.0 enable faster and easier eForms authorization than ever before, and enable caregivers to focus on patients instead of paperwork.”

Anyone who is not attending HIMSS17 but wants to learn more about Access’s paperless electronic signatures and eForms technology can visit the company’s website at http://www.accessefm.com.

About Access

For more than 15 years, Access has developed electronic forms management solutions that eliminate the unnecessary expense, risk and inefficiency of paper forms. Our 100 percent paperless technology enables organizations in any industry to capture, manage, sign and share forms data without printing or scanning. Learn more at http://www.accessefm.com and help Access’s partner The Last Well bring clean water and the Gospel to Liberia at http://thelastwell.org.

Read the full story at http://www.prweb.com/releases/2017/02/prweb14078884.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Trinity Health AND U.S. Soccer Foundation Expand Access to Soccer Program Proven to Positively Impact Children’s Health
2. Salus Telehealth’s VideoMedicine Mobile Platform Offers Liberty HealthShare Members On-Demand Access to Primary Care Physician Services
3. Palliative Care Continues to Grow with Greater Diversity in Patient Diagnoses – Wider Access Still Needed
4. RosettaHealth Introduces “Access Everywhere” Initiative for Sharing Electronic Medical Records at HIMSS 2017
5. Access To Support The Last Well’s Border-to-Border Clean Water Initiative in Liberia at HIMSS17
6. Ft. Lauderdale Dentist Raises Money to Fight Against Poverty and Access to Clean Water
7. Direct Access Lab Offers Sale on Cholesterol Tests
8. Access Healthcare Welcomes Patti Bernstein as Senior Vice President of Client Services
9. LINET Awarded Three Year Agreement with Vizient for Pediatric Beds and Accessories
10. Author Tina Jackson’s Newly Released “Mysteries Revealed On Speaking In Tongues” Is An In-Depth Look At God's Supernatural Language And How Readers Can Access It
11. Statement from UN Foundation President & CEO Kathy Calvin on New Restrictions of U.S. Foreign Assistance to Limit Women’s Access to Health Care Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... ... specializing in medical device compliance and commercialization, has just released a new ... , FDA is more adamant than ever about medical device, pharmaceutical, and ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part of The Garland ... a redesigned website. The new site – still located at http://www.garlandco.com ... and other industry users that Garland serves. , After an ambitious phase of ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... digital and social campaign, “Humans With Vaginas.” The goal is to ignite conversation ... of non-toxic personal care products. The brand has declared September “Humans with Vaginas” ...
(Date:9/20/2017)... ... 20, 2017 , ... Health & Safety Institute (HSI) is offering discounted pricing ... 40-Hour courses from now until November 30, 2017 to assist with the clean-up efforts ... to all businesses and government agencies – whether or not they will be directly ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting story of ... life. This mouse sets out on a journey that will show that friends are ... creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology: